Progress
RAQuantity
1474
Category
Tablet Azacitidine 300 mg10730
Bid Type
Two Packet Bid
A tender has been published for Indian Air Force Tablet Azacitidine 300 mg10730, Goserelin 3_6 mg Prefilled Syringe10875, Tab Sofasbuvir 400 mg and Velpatasvir 100 mg10491, Inj Leuprolide 3_75 mg14712, Syp Levocarnitine 500 mg 100 ml175, Mitomycin C 10mg Inj2191, FOLLITROPIN BETA600 IU RECOMBINANT FSH INJ7653 in BANGALORE, KARNATAKA. Quantity: 1474 by. Submission Deadline: 03-02-2025 14: 00: 00. Check eligibility and apply.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Tablet Azacitidine 300 mg10730 , Goserelin 3_6 mg Prefilled Syringe10875 , Tab Sofasbuvir 400 mg and Velpatasvir 100 mg10491 , Inj Leuprolide 3_75 mg14712 , Syp Levocarnitine 500 mg 100 ml175 , Mitomycin C 10mg Inj2191 , FOLLITROPIN BETA600 IU RECOMBINANT FSH INJ7653
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Tablet Azacitidine 300 mg10730
10730
Goserelin 3_6 mg Prefilled Syringe10875
10875
Tab Sofasbuvir 400 mg and Velpatasvir 100 mg10491
10491
Inj Leuprolide 3_75 mg14712
14712
Syp Levocarnitine 500 mg 100 ml175
175
Mitomycin C 10mg Inj2191
2191
FOLLITROPIN BETA600 IU RECOMBINANT FSH INJ7653
7653
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Tablet Azacitidine 300 mg10730 | 10730 | 84 | tab | medpro-03 | 60 | |
| 2 | Goserelin 3_6 mg Prefilled Syringe10875 | 10875 | 60 | pfs | medpro-03 | 60 | |
| 3 | Tab Sofasbuvir 400 mg and Velpatasvir 100 mg10491 | 10491 | 1,000 | no | medpro-03 | 60 | |
| 4 | Inj Leuprolide 3_75 mg14712 | 14712 | 50 | vial | medpro-03 | 60 | |
| 5 | Syp Levocarnitine 500 mg 100 ml175 | 175 | 180 | no | medpro-03 | 60 | |
| 6 | Mitomycin C 10mg Inj2191 | 2191 | 50 | vial | medpro-03 | 60 | |
| 7 | FOLLITROPIN BETA600 IU RECOMBINANT FSH INJ7653 | 7653 | 50 | no | medpro-03 | 60 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
04-May-2025, 12:00 pm
End
05-May-2025, 12:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 01-02-2025 13:23:48 | |
| 2 | ********** Under PMA | - | 02-02-2025 23:57:51 | |
| 3 | ********** Under PMA | - | 01-02-2025 15:47:06 | |
| 4 | ********** Under PMA | - | 03-02-2025 13:39:59 | |
| 5 | ********** Under PMA | - | 03-02-2025 12:41:10 |
Key insights about KARNATAKA tender market
The eligibility requirements include being a registered entity, with evidence of prior experience in supplying pharmaceutical products, and substantiation of financial capacity through documented turnover. It is mandatory to also provide OEM authorization and any additional documents required for exemptions from criteria.
Bidders are required to submit several certificates including OEM Authorization Certificates, financial capacity proof (turnover), and documents validating past performance regarding similar pharmaceutical supplies. Compliance documents with attached specifications are also required as part of the submission.
Registration requires accessing the appropriate government procurement platform where guidelines and procedures are detailed. Bidders may need to fill out a comprehensive registration form, submit any required documentation, and create an account to access tender details.
Submissions must comply with prescribed formats, typically including PDF or other specified electronic formats as highlighted in the tender documentation. All required documents should be digitally signed or certified.
All products supplied must adhere to stringent quality and safety protocols as defined in the tender's technical specifications. You can find detailed information regarding these specifications in the attached documents provided in the tender.
All pharmaceuticals must comply with national and international quality standards. This will be assessed during the evaluation phase, ensuring that only high-quality products meeting all requirements are accepted.
Yes, all bidders must comply with applicable regulatory frameworks, including those set by health authorities and the Ministry of Defence for pharmaceutical supplies, ensuring that products are safe and effective for military personnel.
Testing criteria involve rigorous quality control assessments which will include verification against the specified standards in the tender documents. Bidders must ensure that their products are readily available for inspection.
The EMD amount for this tender is set at INR 24,360. This deposit is required to demonstrate commitment to the bidding process and will be refunded post-evaluation.
Performance security requirements dictate that awarded bidders may need to submit a security deposit that is typically a percentage of the contract value, ensuring that suppliers adhere to the terms agreed upon in the contract.
Payment terms are determined upon contract finalization and may include interim payments based on milestones or upon successful delivery and acceptance of the drugs by the military authorities.
The price evaluation considers the overall cost, compliance with technical specifications, and total quantities offered. An item-wise evaluation will ensure that the most economically advantageous tenders are selected.
Tender documents must be submitted electronically via the designated government e-procurement platform, ensuring all formats and specifications are followed to facilitate smooth evaluation.
While exact dates must be referenced in the tender documentation, general timelines include document submissions, evaluations, and notifications regarding the results which are crucial for prospective bidders.
Bidders will receive notifications via the registered communication methods outlined in the tender document, following the evaluation process to ensure transparency and effective communication regarding outcomes.
Micro, Small, and Medium Enterprises (MSEs) benefit from relaxed eligibility criteria, which may include exemptions from certain documentation requirements to promote participation from smaller businesses and enhance competitive bidding.
Yes, startups may receive favorable conditions as outlined in the tender, including exemption provisions aimed at fostering innovation and encouraging new market entrants.
Bidders are encouraged to align their offerings with the 'Make in India' initiative, ensuring that locally sourced products and services are prioritized, promoting indigenous manufacturing and reducing reliance on foreign goods.
Yes, adherence to local content and procurement rules is essential, promoting the use of domestically manufactured goods, which can be specified in your tender submission to align with national policies.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS